Daily Archives: October 31, 2022
Guideline | Acute mesenteric ischemia.
31 Oct, 2022 | 13:58h | UTC
ACC Expert consensus for integrating atherosclerotic cardiovascular disease and multimorbidity treatment.
31 Oct, 2022 | 13:59h | UTC
Commentary on Twitter
.@ACCinTouch's newest Expert Consensus Decision Pathway, just published in #JACC, offers a comprehensive and integrative framework for treating patients with #ASCVD and multimorbidity. https://t.co/NAa1aP4OEx#ACCClinicalDoc #CardioTwitter @kofi_larry @virani_md @tygluckman pic.twitter.com/XPePHSwuFL
— JACC Journals (@JACCJournals) October 25, 2022
Perioperative mortality in pediatric patients: a systematic review of risk assessment tools for use in the preoperative setting.
31 Oct, 2022 | 13:57h | UTC
Commentary on Twitter
In a new systemic review of preexisting literature on the prediction of #mortality in #pediatric populations, all chosen models exhibited good performance. However, many had high or unclear risks of bias, and most had not been externally validated. https://t.co/dfw95xgd4y pic.twitter.com/9GxCzrsAD2
— Anesthesiology (@_Anesthesiology) October 21, 2022
M-A of RCT | Comparison of low carbohydrate vs. low fat diets in Type 2 DM.
31 Oct, 2022 | 13:55h | UTC
SR | Immediate versus delayed postpartum insertion of contraceptive implant and IUD for contraception.
31 Oct, 2022 | 13:56h | UTC
RCT | Effects of a low-carbohydrate dietary intervention on hemoglobin A1c.
31 Oct, 2022 | 13:54h | UTCSee also: Visual Abstract
News Release: At risk for diabetes? Cut the carbs, says new study – Tulane University
Commentaries:
Low-Carb Diet Promising for Lowering Blood Sugar in Prediabetes – TCTMD
Dose-reduced direct oral anticoagulants: practical considerations.
31 Oct, 2022 | 13:52h | UTC
RCT | Photodynamic vs. white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer.
31 Oct, 2022 | 13:51h | UTC
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
31 Oct, 2022 | 13:51h | UTCRelated Guideline: ASCO Guideline | Treatment of metastatic colorectal cancer.
Consensus Paper | Diagnosis and management of syncope in hypertrophic cardiomyopathy.
31 Oct, 2022 | 13:49h | UTC
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline.
31 Oct, 2022 | 13:50h | UTC
Cohort Study | Risk factors of pancreatic cancer in patients with Type 2 DM.
31 Oct, 2022 | 13:47h | UTC
M-A | Comparison of continuous versus intermittent enteral feeding in critically ill patients.
31 Oct, 2022 | 13:48h | UTC
Review | Optimal perfusion targets in cardiogenic shock.
31 Oct, 2022 | 13:45h | UTCOptimal Perfusion Targets in Cardiogenic Shock – JACC: Advances
Commentary on Twitter
#CardiogenicShock (CS) carries marked morbidity and mortality, w/ limited data to guide hemodynamic targets. Randomized #clinicaltrials in CS subsets are necessary to better elucidate optimal #perfusion targets. https://t.co/XpmXmlMdww#JACCAdvances #resuscitation #CardioTwitter pic.twitter.com/VWDEYkQ3nm
— JACC Journals (@JACCJournals) July 4, 2022
Evolving presentation of cardiogenic shock: a review of the medical literature and current practices.
31 Oct, 2022 | 13:46h | UTC
Commentary on Twitter
#CardiogenicShock remains a leading cause of morbidity and mortality among patients with #CardiovascularDisease. In his review, authors sought to survey the medical literature and provide an update on current practice. Read this in full here: https://t.co/lA0Hj9PWaM pic.twitter.com/Vz63n5pWfL
— Cardiology and Therapy (@Cardio_Therapy) August 8, 2022
Cohort Study | Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
31 Oct, 2022 | 13:42h | UTC
Commentary on Twitter
New study shows that a subset of HFrEF patients without atrial fibrillation have a stroke risk equivalent to that of patients with AF who are not anticoagulatedhttps://t.co/AXM5ut2SUV#stroke #heartfailure #HF #cardiotwitter @ESC_Journals @escardio pic.twitter.com/Ppa17U79b8
— EHJ Editor-in-Chief (@ehj_ed) August 26, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
M-A of RCT | Combination of ulinastatin and somatostatin evaluated in acute pancreatitis.
31 Oct, 2022 | 13:44h | UTC
Study | No benefit from frailty screening over a geriatric-assessment-for-all approach in older patients with cancer.
31 Oct, 2022 | 13:40h | UTC
Nonsurgical options for risk reduction of contralateral breast cancer in BRCA mutation carriers with early breast cancer.
31 Oct, 2022 | 13:41h | UTCNonsurgical Options for Risk Reduction of Contralateral Breast Cancer in BRCA Mutation Carriers With Early-Stage Breast Cancer – Journal of Clinical Oncology (free for a limited period)
Post-trial follow-up | Pembrolizumab vs. chemotherapy as first-line therapy in PD-L1-expressing non–small-cell lung cancer.
31 Oct, 2022 | 13:39h | UTC
RCT | Effectiveness of rTMS vs. bilateral Theta burst stimulation in older adults with depression.
31 Oct, 2022 | 13:38h | UTCCommentary: Neurostimulation Methods Compared for Treating Depression in Seniors – HealthDay
Commentary on Twitter
Study shows that bilateral theta-burst stimulation achieves a non-inferior reduction in #depression symptoms compared to standard bilateral rTMS, in older adults with treatment-resistant depression https://t.co/S8RZ0Ah3m0 pic.twitter.com/iAzhSj05Vf
— JAMA Psychiatry (@JAMAPsych) September 23, 2022
Post-trial follow-up | Updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab.
31 Oct, 2022 | 13:36h | UTC
Commentary on Twitter
Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab https://t.co/hw7Tp9yjdu pic.twitter.com/CqMu2cMqRc
— Blood Journal (@BloodJournal) August 31, 2022
RCT | Sutimlimab in patients with cold agglutinin disease without recent transfusion.
31 Oct, 2022 | 13:37h | UTCEditorial: A virtuosic CADENZA played by sutimlimab – Blood
Commentary: Sutimlimab Shows Efficacy in Patients With CAD Without Recent Transfusion – AJMC
Commentary on Twitter
Read #openaccess article ‘Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial’ recently published in @BloodJournalhttps://t.co/K13e9V1c0K @ASH_Hematology pic.twitter.com/61oqWewcJ2
— Elsevier Hematology (@ELShematology) September 12, 2022
Case Report | Acquired Hemophilia A secondary to an immune checkpoint inhibitor.
31 Oct, 2022 | 13:34h | UTCCommentary: Report Details Rare Case of Acquired Hemophilia A Secondary to Immune Checkpoint Inhibition
Cohort Study | Association of retinal age gap with arterial stiffness and incident cardiovascular disease.
31 Oct, 2022 | 13:32h | UTCAssociation of Retinal Age Gap With Arterial Stiffness and Incident Cardiovascular Disease – Stroke
Related: